Index Performance
Overview
Description
The healthcare services industry in the U.S. is a robust and dynamic sector, underpinned by the increasing demand for medical services due to demographic shifts such as an aging population, advancements in medical treatments, and a heightened focus on health and wellness precipitated by public health challenges like the COVID-19 pandemic. The growth is also driven by innovation in healthcare technologies and services, such as telemedicine, as well as regulatory changes and governmental policies which influence reimbursement rates and coverage. With the integration of IT in healthcare, the emphasis on cost reduction and outcome improvement, alongside rising insurance coverage, the sector is poised for upward growth. However, it is also susceptible to policy changes, which adds a level of uncertainty to its long-term prospects. Investing within the healthcare services industry can be varied with several subcategories of interest under the given criteria. [[Integrated Healthcare Services]] are businesses that offer a spectrum of services from primary care to specialized surgeries, optimizing coordinated care and potentially offering significant efficiency. [[Healthcare Technology and Data Analytics]] signifies companies that focus on the integration of IT to improve patient care, enhance data management, and support remote healthcare services, which is particularly relevant in an era of increased telemedicine utilization. [[Managed Healthcare Providers]] describes organizations that arrange for the delivery of healthcare services to patients, attempting to reduce healthcare costs while improving quality of care. [[Pharmaceutical Services and Distribution]] encompasses companies involved in the wholesale distribution of pharmaceuticals and health products as well as the provision of value-added services to the healthcare sector. [[Medical Supplies and Devices]] covers firms specializing in the manufacture and supply of medical equipment, which have found increasing demands following global health crises, technological improvements, and the trend of surgeries moving towards outpatient settings. Each of these subcategories have distinct growth drivers and risks, and demand a thorough analysis of financial health, market position, regulatory pressures, and technological adaptability to determine the strongest investment candidates. This index was generated with help from Thematic Assist.
- TickerHCAP
- Inception Date12/03/2023
- WeightingEqual
- # of holdings67
What's inside?
Holdings
All holdings as of May 21, 2025
| Quanta Services, Inc. (PWR) | 1.92% | $51.12B | 23.88% | 11.62% | 1.71 |
| EXACT Sciences Corp. (EXAS) | 1.89% | $10.91B | 10.86% | 70.82% | 3.48 |
| Insulet Corp. (PODD) | 1.83% | $23.05B | 28.82% | 72.79% | 9.04 |
| Leidos Holdings, Inc. (LDOS) | 1.80% | $20.63B | 6.79% | 17.83% | 1.32 |
| IDEXX Laboratories, Inc. (IDXX) | 1.80% | $41.59B | 3.56% | 62.81% | 8.98 |
| Paycom Software, Inc. (PAYC) | 1.79% | $15.07B | 6.13% | 76.66% | 6.20 |
| Cardinal Health, Inc. (CAH) | 1.76% | $36.94B | -0.06% | 3.73% | 0.17 |
| HCA Healthcare, Inc. (HCA) | 1.76% | $92.87B | 5.66% | 15.58% | 1.88 |
| DexCom, Inc. (DXCM) | 1.74% | $34.25B | 12.49% | 56.85% | 6.68 |
| Jabil, Inc. (JBL) | 1.72% | $17.98B | -0.58% | 8.68% | 0.69 |
| ResMed, Inc. (RMD) | 1.69% | $36.38B | 7.92% | 58.49% | 6.54 |
| STERIS Plc (Ireland) (STE) | 1.69% | $24.61B | 6.24% | 49.03% | 4.46 |
| Intuitive Surgical, Inc. (ISRG) | 1.68% | $199.70B | 19.19% | 64.67% | 20.21 |
| Cencora, Inc. (COR) | 1.65% | $56.78B | 10.29% | 3.47% | 0.19 |
| Carrier Global Corp. (CARR) | 1.65% | $64.26B | -15.59% | 27.73% | 2.86 |
| McKesson Corp. (MCK) | 1.65% | $89.98B | 16.22% | 3.48% | 0.25 |
| Edwards Lifesciences Corp. (EW) | 1.63% | $45.66B | -11.61% | 77.93% | 7.13 |
| Neurocrine Biosciences, Inc. (NBIX) | 1.63% | $12.17B | 11.12% | 98.39% | 4.51 |
| Okta, Inc. (OKTA) | 1.62% | $21.96B | 15.33% | 76.32% | 5.73 |
| Xylem, Inc. (XYL) | 1.60% | $30.91B | 1.62% | 36.98% | 3.54 |
| Abbott Laboratories (ABT) | 1.60% | $235.23B | 3.95% | 52.56% | 5.63 |
| Cognizant Technology Solutions Corp. (CTSH) | 1.58% | $39.92B | 7.46% | 30.79% | 1.84 |
| Incyte Corp. (INCY) | 1.58% | $12.64B | 19.53% | 91.49% | 2.18 |
| Ecolab, Inc. (ECL) | 1.58% | $74.39B | -1.52% | 44.32% | 5.07 |
| Boston Scientific Corp. (BSX) | 1.57% | $157.62B | 20.93% | 63.26% | 9.21 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 1.56% | $38.03B | 20.20% | 88.04% | 14.95 |
| Laboratory Corp. of America Holdings (LH) | 1.56% | $20.22B | 5.30% | 26.26% | 1.96 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 1.55% | $19.60B | 0.84% | 47.88% | 2.00 |
| Stryker Corp. (SYK) | 1.55% | $148.87B | 11.88% | 61.83% | 6.84 |
| Quest Diagnostics, Inc. (DGX) | 1.55% | $19.90B | 12.09% | 31.30% | 2.52 |
| Align Technology, Inc. (ALGN) | 1.54% | $13.23B | -1.82% | 69.93% | 2.75 |
| Gilead Sciences, Inc. (GILD) | 1.53% | $135.73B | -0.60% | 76.83% | 5.47 |
| Walgreens Boots Alliance, Inc. (WBA) | 1.52% | $9.71B | 4.15% | 16.39% | 0.26 |
| Tencent Holdings Ltd. (TCEHY) | 1.52% | $598.05B | 11.49% | 54.35% | 6.43 |
| Roper Technologies, Inc. (ROP) | 1.52% | $62.17B | 12.02% | 68.71% | 9.79 |
| Veeva Systems, Inc. (VEEV) | 1.50% | $39.24B | 16.20% | 74.03% | 12.19 |
| United Therapeutics Corp. (UTHR) | 1.50% | $13.96B | 17.22% | 88.36% | 3.96 |
| Sony Group Corp. (SONY) | 1.49% | $160.19B | -5.61% | 28.27% | 1.90 |
| Ventas, Inc. (VTR) | 1.45% | $87.95B | 13.18% | 20.10% | 8.63 |
| SS&C Technologies Holdings, Inc. (SSNC) | 1.44% | $19.83B | 5.50% | 49.35% | 4.01 |
| Medtronic Plc (MDT) | 1.43% | $110.77B | 2.51% | 61.31% | 4.06 |
| Johnson & Johnson (JNJ) | 1.42% | $369.72B | 2.39% | 66.84% | 4.59 |
| CVS Health Corp. (CVS) | 1.41% | $80.63B | 6.96% | 15.24% | 0.41 |
| Viatris, Inc. (VTRS) | 1.40% | $10.42B | -11.28% | 37.45% | 1.68 |
| Baxter International, Inc. (BAX) | 1.39% | $16.14B | -26.92% | 35.39% | 2.15 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 1.39% | $66.38B | -3.70% | 80.48% | 4.61 |
| West Pharmaceutical Services, Inc. (WST) | 1.38% | $15.48B | 0.42% | 33.33% | 5.61 |
| Agilent Technologies, Inc. (A) | 1.37% | $32.35B | 1.39% | 53.60% | 6.95 |
| Biogen, Inc. (BIIB) | 1.36% | $19.13B | 6.17% | 65.22% | 2.56 |
| Hologic, Inc. (HOLX) | 1.35% | $12.58B | -1.23% | 55.40% | 3.66 |
| Pfizer Inc. (PFE) | 1.33% | $133.72B | -7.82% | 71.65% | 3.03 |
| AbbVie, Inc. (ABBV) | 1.32% | $326.52B | 8.39% | 70.00% | 7.60 |
| Eli Lilly & Co. (LLY) | 1.31% | $707.97B | 45.17% | 82.53% | 15.90 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 1.31% | $114.83B | 2.19% | 86.78% | 10.98 |
| Teleflex, Inc. (TFX) | 1.30% | $5.61B | -5.04% | 55.62% | 2.67 |
| Amgen, Inc. (AMGN) | 1.30% | $147.87B | 9.42% | 63.33% | 6.40 |
| GE Healthcare Technologies, Inc. (GEHC) | 1.29% | $32.90B | 2.73% | 41.78% | 2.22 |
| Zimmer Biomet Holdings, Inc. (ZBH) | 1.27% | $18.86B | 1.05% | 62.29% | 3.69 |
| Merck & Co., Inc. (MRK) | 1.26% | $195.79B | -1.20% | 75.13% | 3.96 |
| BioMarin Pharmaceutical, Inc. (BMRN) | 1.24% | $11.49B | 12.72% | 79.31% | 4.53 |
| Charles River Laboratories International, Inc. (CRL) | 1.22% | $7.05B | -2.71% | 27.93% | 2.66 |
| Bristol Myers Squibb Co. (BMY) | 1.18% | $97.42B | -5.60% | 65.53% | 3.44 |
| Thermo Fisher Scientific, Inc. (TMO) | 1.16% | $156.19B | 0.18% | 40.96% | 5.08 |
| Avantor, Inc. (AVTR) | 1.15% | $9.18B | -5.86% | 33.82% | 2.22 |
| IQVIA Holdings, Inc. (IQV) | 1.12% | $25.08B | 2.43% | 27.02% | 2.83 |
| Alexandria Real Estate Equities, Inc. (ARE) | 1.10% | $12.49B | -1.42% | 25.02% | 10.77 |
| ICON plc (ICLR) | 1.04% | $10.67B | -4.26% | 23.12% | 2.10 |
